Sep 24 2015
Silicon Valley Business Journal
Auris Health, Inc, formerly known as Auris Surgical Robotics, was featured for its impressive $150 million Series B funding. The article also mentioned Auris’s previous financial partners, which include Peter Theil's Mithril Capital, and its total financing to date.
Excerpts from the article: “The San Carlos company didn't say where the money came from but investors in its Series A round in March 2014 included Peter Thiel's Mithril Capital Management, Lux Capital, NaviMed Capital and Highland Capital Partners.”
“The company has now raised a total of $185 million.”Read the Full Article about Auris
Complications from bronchoscopy are rare and most often minor, but if they occur, may include breathing difficulty, vocal cord spasm, hoarseness, slight fever, vomiting, dizziness, bronchial spasm, infection, low blood oxygen, bleeding from biopsied site, or an allergic reaction to medications. Only rarely do patients experience other more serious complications (for example, collapsed lung, respiratory failure, heart attack and/or cardiac arrhythmia).
Adverse effects from both Mini-PCNL and Ureteroscopy include pain, urinary tract infection, fever, hematuria (presence of blood in urine), exposure to low levels of radiation, retained or residual stones.
Adverse effects from ureteroscopy may include pain, perforation or injury to the ureter, resulting in extravasation of fluid and urine (urinoma), stricture of the ureter with risk of subsequent obstruction (hydronephrosis needing further repair), rare avulsion of the ureter, urinary blood clots, residual stones.
PCNL access may result in minor and major adverse effects. Minor effects include fever and nephrostomy leak. Major adverse effects may include injuries to pleura, liver, spleen, large vessels with related bleeding, gallbladder, duodenum, jejunum, colon with related cutaneous fistula, fever, pain, ileus, elevated counts.
Major adverse effects related to stone removal may include infection and urosepsis, intravascular fluid overload, extravasation of fluid, and post percutaneous nephrolithotomy bleeding.